Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Vaxil Bio Ltd.
  6. News
  7. Summary
    VXL   CA92243L1076

VAXIL BIO LTD.

(VXL)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021

05/31/2021 | 12:57pm EDT

Vaxil Bio Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was CAD 258,000 compared to CAD 171,000 a year ago. Net loss was CAD 258,000 compared to CAD 173,000 a year ago.


© S&P Capital IQ 2021
All news about VAXIL BIO LTD.
10/17VAXIL BIO : Signs letter of intent to acquire a 100% interest in short wave pharma inc.
PU
10/15VAXIL BIO : Announces progress on research and development activities
PU
10/14VAXIL BIO : Reports Letter of Intent to Buy 100% Interest in Short Wave Pharma; Up 10%
MT
10/14VAXIL BIO : IIROC Trading Resumption - VXL
AQ
10/14VAXIL BIO : Reports Letter of Intent to Buy 100% Interest in Short Wave Pharma
MT
10/14VAXIL BIO : Signs Letter of Intent to Acquire a 100% Interest in Short Wave Pharma Inc.
AQ
10/14VAXIL BIO : IIROC Trading Halt - VXL
AQ
10/14Vaxil Bio Ltd. entered into a non-binding letter of agreement to acquire Short Wave Pha..
CI
10/12VAXIL BIO : up 21% as Provides Update on Research and Development Activities
MT
10/12VAXIL BIO : Provides Update on Research and Development Activities
MT
More news
Financials
Sales 2020 - - -
Net income 2020 -1,36 M -1,10 M -1,10 M
Net cash 2020 1,50 M 1,21 M 1,21 M
P/E ratio 2020 -22,5x
Yield 2020 -
Capitalization 14,4 M 11,6 M 11,6 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 91,2%
Chart VAXIL BIO LTD.
Duration : Period :
Vaxil Bio Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VAXIL BIO LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Managers and Directors
Yuval Avnir Chief Executive Officer
Gadi Levin Chairman & Chief Financial Officer
Terry F. Plasse Chief Medical Officer
Ari S. Kellen Independent Director
Shawn Langer Independent Director
Sector and Competitors
1st jan.Capi. (M$)
VAXIL BIO LTD.-65.00%12
MODERNA, INC.212.57%131 807
LONZA GROUP AG32.74%61 177
IQVIA HOLDINGS INC.43.38%49 092
SEAGEN INC.-2.12%31 189
CELLTRION, INC.-38.86%25 455